Search
for

    Sort by

    Research 181–210 of 1000+

    1. Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications Preprints.org · 2025
    2. Surgical Management of Severe Cicatricial Ectropion Secondary to Pityriasis Rubra Pilaris. Dermatologic Surgery · 2025
    3. Successful treatment of severe diffuse alopecia areata with abrocitinib Anais Brasileiros de Dermatologia · 2025
    4. Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients Acta Dermatovenerologica Alpina Pannonica et Adriatica · 2025
    5. Permanent Makeup Removal Severe Complication—Case Report and Proposal of the Protocol for Its Management Journal of Clinical Medicine · 2024
    6. 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials Journal of the American Academy of Dermatology · 2024
    7. Ritlecitinib in severe alopecia areata: a profile of its use Drugs & Therapy Perspectives · 2024
    8. Diphenylcyclopropenone in severe alopecia areata in children and adolescents: long-term follow-up and relapse rate Journal of the Egyptian Womenʼs Dermatologic Society · 2024
    9. Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up Journal of asthma and allergy · 2024
    10. Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey Clinical, cosmetic and investigational dermatology · 2024
    11. Treatment of moderate-to-severe alopecia areata in patients over the age of 65 with baricitinib Clinical and Experimental Dermatology · 2024
    12. Tofacitinib treatment in a severe pediatric alopecia areata: A case report and a literature review Skin Research and Technology · 2024
    13. First drug for severe alopecia recommended by NICE could benefit 14,000 patients 2024
    14. RETRACTED: The impact of different antibiotic injection regimens on patients with severe infections: A meta‐analysis International Wound Journal · 2024
    15. When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials British Journal of Dermatology · 2023
    16. Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser 2023
    17. Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case series Clinical and Experimental Dermatology · 2023
    18. ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS PARIPEX INDIAN JOURNAL OF RESEARCH · 2023
    19. Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients Journal of The American Academy of Dermatology · 2023
    20. A Paediatric Case of Severe Allergic Conjunctivits with Underlying Alopecia Areata Malaysian Journal of Medical Research · 2023
    21. A Rare Case of Severe Acrodermatitis Enteropathica During Covid-19 Lockdown. 2022
    22. Alopecia areata after severe allergic contact dermatitis to a permanent hair dye Contact dermatitis · 2022
    23. Diffused alopecia followed by severe acute respiratory syndrome coronavirus-2 infection Libyan journal of medical sciences · 2021
    24. G588(P) Transient renal and hepatic dysfunction in severe profound hypothyroidism 2019
    25. Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report 대한피부과학회지 · 2018
    26. A Case of Azathioprine Induced Severe Myelosuppression and Alopecia Totalis in IgA Nephropathy Childhood Kidney Diseases · 2017
    27. Poster 148 Severe Hair Loss during Inpatient Rehabilitation due to Telogen Effluvium: A Case Report PM&R · 2014
    28. Eczémas de contact atypiques ou sévères à l’huile essentielle de cannelle Annales de Dermatologie et de Vénéréologie · 2013
    29. Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience DOAJ (DOAJ: Directory of Open Access Journals) · 2010
    30. Syndromes of Severe Insulin Resistance (SSIRs) 2004